Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript
| - Industry | - Sector | Robert P. Mauch PharmD CEO | XDUS Exchange | US03073E1055 ISIN |
| US Country | 42,000 Employees | 14 Nov 2025 Last Dividend | 16 Jun 2009 Last Split | - IPO Date |
Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.
U.S. Healthcare Solutions:
International Healthcare Solutions: